Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

KPL-716-C201: A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of KPL-716 in Reducing Pruritus in Subjects with Prurigo Nodularis (IRB 239539)


Collapse Overview 
Collapse sponsor award id
KPL-716-C201


Collapse Biography 

Collapse Time 
Collapse start date
2019-11-22